APA

Yamamoto K. N., Nakamura A., Liu L. L., Stein S., Tramontano A. C., Kartoun U., Shimizu T., Inoue Y., Asakuma M., Haeno H., Kong C. Y., Uchiyama K., Gonen M., Hur C. & Michor F. (20200214). Computational modeling of pancreatic cancer patients receiving FOLFIRINOX and gemcitabine-based therapies identifies optimum intervention strategies. : PloS one.

Chicago

Yamamoto Kimiyo N, Nakamura Akira, Liu Lin L, Stein Shayna, Tramontano Angela C, Kartoun Uri, Shimizu Tetsunosuke, Inoue Yoshihiro, Asakuma Mitsuhiro, Haeno Hiroshi, Kong Chung Yin, Uchiyama Kazuhisa, Gonen Mithat, Hur Chin and Michor Franziska. 20200214. Computational modeling of pancreatic cancer patients receiving FOLFIRINOX and gemcitabine-based therapies identifies optimum intervention strategies. : PloS one.

Harvard

Yamamoto K. N., Nakamura A., Liu L. L., Stein S., Tramontano A. C., Kartoun U., Shimizu T., Inoue Y., Asakuma M., Haeno H., Kong C. Y., Uchiyama K., Gonen M., Hur C. and Michor F. (20200214). Computational modeling of pancreatic cancer patients receiving FOLFIRINOX and gemcitabine-based therapies identifies optimum intervention strategies. : PloS one.

MLA

Yamamoto Kimiyo N, Nakamura Akira, Liu Lin L, Stein Shayna, Tramontano Angela C, Kartoun Uri, Shimizu Tetsunosuke, Inoue Yoshihiro, Asakuma Mitsuhiro, Haeno Hiroshi, Kong Chung Yin, Uchiyama Kazuhisa, Gonen Mithat, Hur Chin and Michor Franziska. Computational modeling of pancreatic cancer patients receiving FOLFIRINOX and gemcitabine-based therapies identifies optimum intervention strategies. : PloS one. 20200214.